Macquarie initiated coverage of Privia Health with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/10/2025 | $25.00 | Buy | Needham |
| 12/16/2024 | Outperform | Macquarie | |
| 10/11/2024 | $23.00 | Overweight | KeyBanc Capital Markets |
| 5/30/2024 | $23.00 | Outperform | Robert W. Baird |
| 4/22/2024 | $25.00 | Buy | Citigroup |
| 3/6/2024 | $22.00 | Equal Weight | Barclays |
| 2/26/2024 | $33.00 → $25.00 | Buy | Jefferies |
| 2/22/2024 | $21.00 | Buy → Neutral | BofA Securities |
DEFA14A - Privia Health Group, Inc. (0001759655) (Filer)
DEF 14A - Privia Health Group, Inc. (0001759655) (Filer)
144 - Privia Health Group, Inc. (0001759655) (Subject)
IMS is One of the Largest Independent Multi-Specialty Practices in the State Arizona Represents 15th State in National Primary Care-Centric Care Delivery Network ARLINGTON, Va., April 09, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced it has signed a definitive agreement to enter Arizona in partnership with Integrated Medical Services, Inc. (IMS), one of the largest independent multi-specialty practices in the state, with approximately 70 physicians and advanced practice providers caring for patients in 21 locations. The group manages over 28,000 attributed lives in a variety of value-based care arrangements across Commercial, Medicare, Medicare Advantage and
ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 before market open on Thursday, May 8, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations t
All 2024 Operating and Financial Metrics Above High End of Guidance RangesVery strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital ExpendituresYear-end 2024 Cash Balance of $491.1 million and No Debt2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. Each of the Company'
ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 before market open on Thursday, May 8, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations t
All 2024 Operating and Financial Metrics Above High End of Guidance RangesVery strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital ExpendituresYear-end 2024 Cash Balance of $491.1 million and No Debt2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. Each of the Company'
ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, February 27, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-
Needham initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00
Macquarie initiated coverage of Privia Health with a rating of Outperform
KeyBanc Capital Markets initiated coverage of Privia Health with a rating of Overweight and set a new price target of $23.00
ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us
ARLINGTON, Va., April 12, 2023 (GLOBE NEWSWIRE) -- Privia Health (NASDAQ:PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the Company's President and Chief Operating Officer, has been named Chief Executive Officer, effective July 1, 2023. Mehrotra is succeeding current CEO, Shawn Morris, who is retiring and will remain on the Company's Board of Directors. Under Morris' leadership since early 2018, Privia Health progressed from a private, regional organization into a publicly-traded company with national reach. During that time, the Company entered eight new states, completed a successful IPO in April 2021, and increased it
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)